New Mexico Administrative Code
Title 8 - SOCIAL SERVICES
Chapter 321 - SPECIALIZED BEHAVIORAL HEALTH SERVICES
Part 10 - OPIOID TREATMENT PROGRAMS
Section 8.321.10.21 - DOSAGE
Universal Citation: 8 NM Admin Code 8.321.10.21
Current through Register Vol. 35, No. 18, September 24, 2024
The program sponsor shall ensure that:
A. a dose of opioid dependency treatment medication is administered only after an order from the program medical director;
B. a patient's dosage of opioid dependency treatment medication is individually determined;
C. a dose of opioid dependency treatment medication is sufficient to produce the desired response in a patient for the desired duration of time and with consideration for patient safety;
D. a dose of opioid dependency medication is prescribed to meet a patient's treatment needs by:
(1) preventing the onset of subjective or
objective signs of withdrawal for 24 hours or more;
(2) reducing or eliminating the drug craving
that is experienced by opioid dependent individuals who are not in opioid
treatment;
(3) a patient receiving
comprehensive maintenance treatment receives an initial dose of opioid
dependency treatment medication based upon the program medical director or
medical practitioner designee's physical examination and with consideration for
local issues, such as the relative purity of available illicit opioid
drugs;
(4) a patient receiving
methadone in comprehensive maintenance treatment receives an initial dose of
methadone that does not exceed 30 milligrams; and
(a) if the patient's withdrawal symptoms are
not suppressed after the initial dose of 30 milligrams, a patient receives an
additional dose that does not exceed 10 milligrams only if a program clinician
documents in the patient record that 30 milligrams did not suppress the
patient's withdrawal symptoms; and
(b) if the patient's withdrawal symptoms are
not suppressed by a total dose of 40 milligrams, a patient receives an
additional dose only if the program medical director or medical practitioner
designee documents in the patient record that 40 milligrams did not suppress
the patient's withdrawal symptoms;
(5) a patient receiving buprenorphine in
opioid treatment withdrawal procedure or comprehensive maintenance treatment
receive an initial dose according to the instructions on the opioid dependency
treatment medication package insert, and any deviation from the instructions is
documented by the program clinician in the patient record;
(6) a patient receives subsequent doses of
opioid dependency treatment medication:
(a)
based on the patient's individual needs and the results of the physical
examination and assessment;
(b)
sufficient to achieve the desired response for at least 24 hours, with
consideration for day-to-day fluctuations and elimination patterns;
(c) that are not used to reinforce positive
behavior or punish negative behavior;
(d) as long as the patient benefits from and
desires comprehensive maintenance treatment; and
(e) that are adjusted if a provider changes
from one type of opioid dependency treatment medication to another.
Disclaimer: These regulations may not be the most recent version. New Mexico may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
